The adhesive is not the component that keeps the patch on the patient. It is the formulation, and the physical state of the drug inside it is a design choice whether or not anyone makes it deliberately.
- Rethinking Drug Delivery To Combat Antibiotic Resistance
- The Resurgence Of Fervor For Oral Delivery
- Advancing Multi-Pathology Disease-Modifying Therapy For Neurodegenerative Diseases
- Container Closure Systems For Biosimilars: Is There Regulatory Difference?
- Qualification And Validation Of Depyrogenation Tunnels And Autoclaves
- FDA Modernizes Container Closure Guidance: What Is Changing And Why It Matters
- Engineering Better ADCs, Part 2: Characterization, CMC, And More
- What Patients Actually Want From Connected Drug Delivery
ON-DEMAND WEBINARS
Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.
Explore how our on-body delivery system supports high-volume biologic delivery by balancing usability, patient needs, and sustainability through research-driven design.
Strengthen risk mitigation strategies while ensuring regulatory alignment. Gain valuable insights into best practices and proactive approaches for building a robust and future-ready CCS.
Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Simplify the journey]( "Delivering Macromolecules: Challenges Associated With The Delivery Of Biologic Drugs")
Delivering Macromolecules: Challenges Associated With The Delivery Of Biologic DrugsDevelopers need to look beyond the formulation of a stable drug all the way to patient compliance. Numerous pitfalls exist along the journey to bring a biologic combination product to market. This integrated solutions program can help you simplify the journey.
-
![iStock-146792998-capsule-powder-pill]( "Precision Powder-In-Capsule Micro-Dosing Accelerates Drug Development")
Precision Powder-In-Capsule Micro-Dosing Accelerates Drug DevelopmentPrecision powder microdosing makes it possible to quickly get formulations to the clinic, saving time, money, and use of limited APIs.
-
![iStock-843765220-pill-glove]( "Achieve Release Profiles And Select Excipients For Formulation Development")
Achieve Release Profiles And Select Excipients For Formulation DevelopmentThe formulation and manufacture of modified-release OSD forms are highly specialized. Review considerations for planning and executing a successful modified release oral solid dosage formulation.
-
![GettyImages-851771510-eye-futuristic-scanning]( "Ophthalmic Drug Delivery")
Ophthalmic Drug DeliveryExplore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.
-
![GettyImages-512752430-lyophilization]( "Lyophilization Contract Manufacturing Services: What To Know")
Lyophilization Contract Manufacturing Services: What To KnowExplore the best ways to optimize your lyophilization cycle and the benefits of partnering with an experienced pharmaceutical contract manufacturing services provider.
-
![Vaccine injectable vials and syringe GettyImages-1252804942]( "A Step Change In Pharmaceutical Glass Packaging Innovation")
A Step Change In Pharmaceutical Glass Packaging InnovationValor Glass represents a significant, and much needed, step forward for glass innovation. Review the findings and learn how an aluminosilicate formulation can lower your glass vials' extractables profile.
-
![West-Production_Faility]( "Successful Industrialization Requires Solid Foundations")
Successful Industrialization Requires Solid FoundationsLearn how choosing the appropriate quality of containment systems from the outset is critical to the successful industrialisation of an injectable drug product and review some of the associated challenges.
-
![sterile-injection-capsules]( "Collaborating With A CMO To Bring Your Sterile Injectable Product To Market")
Collaborating With A CMO To Bring Your Sterile Injectable Product To MarketReview considerations for collaborating with a fill/finish CMO, including CMO selection, Request for Proposal (RFP) delivery, proposal review, and project award.
-
![Bio Manufacturing GettyImages-1219894348]( "A Technical Package That Serves On-Time Injectable Project Completion")
A Technical Package That Serves On-Time Injectable Project CompletionThe accuracy, robustness, and completeness of the technical package an organization submits to its development and/or manufacturing partner is critical to meeting fill project timelines.
-
![GettyImages-949946968-lab-research]( "A Risk-Based Approach To Injectable Combination Product Development")
A Risk-Based Approach To Injectable Combination Product DevelopmentExamine how to establish a holistic approach to drug-device combination product (DDCP) development and how to assess and manage risk throughout the development and approval process.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![Delivered _by _DeGrazio_Logo_Color_2]( "Container Closure Systems For Biosimilars: Is There Regulatory Difference?")
Container Closure Systems For Biosimilars: Is There Regulatory Difference?In this article, Fran DeGrazio discusses the FDA’s draft guidance on container closure systems for biosimilar products. She highlights key takeaways and offers recommendations on implications that developers of biosimilar pharmaceutical products should consider in areas such as quality, testing, and documentation.
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts.
